Published on
February 2, 2026
- 16:35 GMT
Orbiton Theragnostics Launches as a Premier Integrated Partner for Nuclear Medicine and Precision Cancer Care
Orbiton Theragnostics to offer pre-clinical & clinical services, contract research & CDMO, isotope supply, and new product development VANCOUVER, BC, CANADA, February 2, 2026 /EINPresswire.com/ -- Orbiton Theragnostics, a Canadian-based …
Distribution channels:
Chemical Industry, Healthcare & Pharmaceuticals Industry
...
